Morgan Stanley’s VistaGen Therapeutics VTGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.3K Sell
12,147
-39,138
-76% -$78.3K ﹤0.01% 6589
2025
Q1
$128K Buy
51,285
+34,193
+200% +$85.5K ﹤0.01% 5907
2024
Q4
$50.4K Buy
17,092
+11,773
+221% +$34.7K ﹤0.01% 6286
2024
Q3
$16K Sell
5,319
-547
-9% -$1.65K ﹤0.01% 6572
2024
Q2
$20.4K Sell
5,866
-15,593
-73% -$54.3K ﹤0.01% 6450
2024
Q1
$113K Sell
21,459
-17,689
-45% -$93.4K ﹤0.01% 5936
2023
Q4
$201K Buy
39,148
+36,588
+1,429% +$188K ﹤0.01% 5946
2023
Q3
$13.4K Sell
2,560
-860
-25% -$4.51K ﹤0.01% 6616
2023
Q2
$6.4K Sell
3,420
-2,685
-44% -$5.02K ﹤0.01% 6928
2023
Q1
$22.8K Sell
6,105
-2,208
-27% -$8.26K ﹤0.01% 6576
2022
Q4
$25.7K Buy
8,313
+3,150
+61% +$9.73K ﹤0.01% 6569
2022
Q3
$24K Buy
5,163
+833
+19% +$3.87K ﹤0.01% 6722
2022
Q2
$114K Sell
4,330
-19,846
-82% -$523K ﹤0.01% 6205
2022
Q1
$899K Buy
24,176
+12,730
+111% +$473K ﹤0.01% 5073
2021
Q4
$669K Buy
11,446
+9,715
+561% +$568K ﹤0.01% 5374
2021
Q3
$142K Sell
1,731
-5,253
-75% -$431K ﹤0.01% 6184
2021
Q2
$660K Sell
6,984
-14,068
-67% -$1.33M ﹤0.01% 5346
2021
Q1
$1.35M Buy
21,052
+20,634
+4,936% +$1.32M ﹤0.01% 4539
2020
Q4
$24K Hold
418
﹤0.01% 6381
2020
Q3
$9K Hold
418
﹤0.01% 6310
2020
Q2
$7K Hold
418
﹤0.01% 6248
2020
Q1
$6K Hold
418
﹤0.01% 6159
2019
Q4
$9K Sell
418
-1
-0.2% -$22 ﹤0.01% 6292
2019
Q3
$13K Sell
419
-2
-0.5% -$62 ﹤0.01% 6136
2019
Q2
$9K Buy
421
+3
+0.7% +$64 ﹤0.01% 6172
2019
Q1
$16K Buy
+418
New +$16K ﹤0.01% 6079
2018
Q1
Sell
-15
Closed 6705
2017
Q4
$0 Buy
+15
New ﹤0.01% 6659